ERBB2 and breast cancer: Moreover, scRNA-seq studies on TNBC identified indicative combinations of the expression of ER, PR, GATA3, E-cadherin and multiple cytokeratins for HER2+ BC, or high levels of Ki-67, p53, EGFR and the hypoxia marker CAIX [48].